share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

施贵宝 | 4:持股变动声明-高管 Shanahan Karin
SEC announcement ·  04/03 06:50
牛牛AI助手已提取核心信息
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
2024年4月1日,百时美施贵宝(BMY)全球产品开发与供应执行副总裁卡琳·沙纳汉完成了一项涉及该公司普通股的股票交易。沙纳汉行使期权免费收购了3,306股股票,随后以每股52.99美元的价格出售了1,196股股票,总销售价值为63,376.04美元。在这些交易之后,沙纳汉直接持有百时美施贵宝的5,336股股份。此外,沙纳汉通过BMS储蓄和投资计划间接拥有818.59股股票的所有权。
2024年4月1日,百时美施贵宝(BMY)全球产品开发与供应执行副总裁卡琳·沙纳汉完成了一项涉及该公司普通股的股票交易。沙纳汉行使期权免费收购了3,306股股票,随后以每股52.99美元的价格出售了1,196股股票,总销售价值为63,376.04美元。在这些交易之后,沙纳汉直接持有百时美施贵宝的5,336股股份。此外,沙纳汉通过BMS储蓄和投资计划间接拥有818.59股股票的所有权。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成,只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。